CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Historical Holders from Q4 2021 to Q1 2025

Symbol
CERO on Nasdaq
CUSIP
71902K105
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
5.17M
All holders as of March 31, 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-19
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ATWOOD BRIAN G 9.9% +45.7% $20.5K $12.4K 512K +153% Brian G. Atwood Mar 31, 2025
YK Bioventures Opportunities GP I, LLC 0% $680 17K YK Bioventures Opportunities GP I, LLC Dec 13, 2024

Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$956K 0
2024 Q4 13.3M $956K +$583K $0.06 19
2024 Q3 3.43M $318K +$159K $0.09 16
2024 Q2 1.87M $557K +$77.5K $0.30 14
2024 Q1 1.52M $4.65M -$2.75M $3.07 8
2023 Q4 54.6K $601K -$206K $11.00 1
2023 Q3 830K $7.33M -$3.25M $10.86 10
2023 Q2 977K $10.6M -$2.06M $10.90 13
2023 Q1 1.23M $11.5M -$85.9M $10.68 14
2022 Q4 9.85M $101M -$49.5M $10.27 45
2022 Q3 15.2M $153M +$5.5M $10.09 65
2022 Q2 14.4M $145M +$6.29M $10.02 54
2022 Q1 13.7M $137M +$31.7M $10.00 45
2021 Q4 10.5M $104M +$90.4M $9.91 36